News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
110,891 Results
Type
Article (4285)
Company Profile (20)
Press Release (106586)
Multimedia
Podcasts (1)
Webinars (2)
Section
Business (31988)
Career Advice (109)
Deals (5254)
Drug Delivery (5)
Drug Development (5416)
Employer Resources (11)
FDA (3203)
Job Trends (2080)
News (46987)
Policy (3874)
Tag
Academia (366)
Accelerated approval (2)
Allergies (10)
Alliances (11213)
ALS (14)
Alzheimer's disease (381)
Antibody-drug conjugate (ADC) (11)
Approvals (3266)
Artificial intelligence (163)
Autoimmune disease (11)
Automation (11)
Bankruptcy (45)
Best Places to Work (1718)
BIOSECURE Act (1)
Biosimilars (11)
Biotechnology (11)
Bladder cancer (23)
Brain cancer (7)
Breast cancer (143)
Cancer (879)
Cardiovascular disease (53)
Career advice (100)
Career pathing (2)
CAR-T (16)
CDC (1)
Celiac Disease (1)
Cell therapy (41)
Cervical cancer (10)
Clinical research (4413)
Collaboration (353)
Compensation (26)
Complete response letters (3)
COVID-19 (486)
CRISPR (6)
C-suite (106)
Cystic fibrosis (14)
Data (655)
Decentralized trials (1)
Depression (14)
Diabetes (32)
Diagnostics (6122)
Digital health (19)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (27)
Drug pricing (4)
Drug shortages (2)
Duchenne muscular dystrophy (6)
Earnings (10925)
Editorial (1)
Employer branding (2)
Employer resources (11)
Events (14053)
Executive appointments (150)
FDA (3632)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (227)
Gene editing (8)
Generative AI (10)
Gene therapy (25)
GLP-1 (51)
Government (628)
Guidances (63)
Healthcare (2916)
HIV (9)
IgA nephropathy (3)
Immunology and inflammation (7)
Immuno-oncology (4)
Indications (7)
Infectious disease (527)
Inflammatory bowel disease (14)
Influenza (21)
Intellectual property (26)
Interviews (12)
IPO (1810)
IRA (2)
Job creations (402)
Job search strategy (94)
JPM (2)
Kidney cancer (6)
Labor market (3)
Layoffs (24)
Leadership (1)
Legal (536)
Liver cancer (14)
Longevity (2)
Lung cancer (105)
Lymphoma (59)
Machine learning (7)
Management (3)
Manufacturing (98)
MASH (18)
Medical device (2525)
Medtech (2537)
Mergers & acquisitions (3622)
Metabolic disorders (74)
Multiple sclerosis (41)
NASH (3)
Neurodegenerative disease (48)
Neuropsychiatric disorders (3)
Neuroscience (510)
NextGen: Class of 2026 (703)
Non-profit (553)
Now hiring (3)
Obesity (21)
Opinion (17)
Ovarian cancer (30)
Pain (10)
Pancreatic cancer (32)
Parkinson's disease (28)
Partnered (3)
Patents (49)
Patient recruitment (39)
Peanut (4)
People (9203)
Pharmaceutical (1)
Pharmacy benefit managers (2)
Phase 1 (1306)
Phase 2 (1827)
Phase 3 (1705)
Pipeline (647)
Policy (4)
Postmarket research (212)
Preclinical (602)
Press Release (11)
Prostate cancer (76)
Psychedelics (1)
Radiopharmaceuticals (131)
Rare diseases (57)
Real estate (871)
Recruiting (5)
Regulatory (3254)
Reports (10)
Research institute (437)
Resumes & cover letters (15)
Rett syndrome (4)
RSV (2)
Schizophrenia (3)
Series A (29)
Series B (23)
Service/supplier (1)
Sickle cell disease (1)
Spinal muscular atrophy (10)
Sponsored (7)
Startups (625)
Stomach cancer (2)
Supply chain (8)
The Weekly (1)
Vaccines (52)
Venture capital (12)
Weight loss (8)
Women's health (23)
Date
Last 7 days (86)
Last 30 days (290)
Last 365 days (3842)
2026 (368)
2025 (4061)
2024 (5116)
2023 (6128)
2022 (10209)
2021 (9617)
2020 (8992)
2019 (6146)
2018 (4853)
2017 (5399)
2016 (5389)
2015 (6109)
2014 (4630)
2013 (4127)
2012 (4435)
2011 (4631)
2010 (4078)
Location
Africa (134)
Alabama (7)
Alaska (1)
Arizona (75)
Arkansas (2)
Asia (5449)
Australia (1307)
California (1345)
Canada (391)
China (61)
Colorado (110)
Connecticut (80)
Delaware (12)
Europe (15670)
Florida (204)
Georgia (65)
Idaho (4)
Illinois (170)
India (14)
Indiana (64)
Iowa (7)
Japan (49)
Kansas (14)
Kentucky (9)
Louisiana (5)
Maine (22)
Maryland (158)
Massachusetts (712)
Michigan (96)
Minnesota (103)
Mississippi (1)
Missouri (44)
Montana (6)
Nebraska (8)
Nevada (5)
New Hampshire (22)
New Jersey (267)
New Mexico (17)
New York (459)
North Carolina (249)
North Dakota (7)
Northern California (652)
Ohio (49)
Oklahoma (5)
Oregon (10)
Pennsylvania (130)
Rhode Island (7)
South America (156)
South Carolina (9)
Southern California (522)
Tennessee (59)
Texas (381)
United States (5270)
Utah (167)
Virginia (70)
Washington D.C. (9)
Washington State (131)
West Virginia (1)
Wisconsin (64)
Wyoming (2)
110,891 Results for "interpace diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Interpace Biosciences Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure
January 21, 2026
·
6 min read
Press Releases
Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results
November 13, 2025
·
11 min read
Press Releases
Interpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association® (ATA) Annual Meeting
September 16, 2025
·
6 min read
Press Releases
Interpace Biosciences Announces Second Quarter 2025 Financial and Business Results
August 8, 2025
·
9 min read
Press Releases
Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk
April 25, 2025
·
6 min read
Pharm Country
Interpace Diagnostics Announces New Data Analyzing Imbalance of Short Tandem Repeat Alleles for Pancreatic Cancer Detection Published as an ASCO 2024 Abstract
Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, is proud to announce that new data demonstrating the application of advanced sequencing technologies in pancreatic cancer was published as an e-abstract as part of the 2024 American Society of Clinical Oncology Annual Meeting.
June 4, 2024
·
6 min read
Press Releases
Interpace Biosciences Announces First Quarter 2025 Financial and Business Results
May 9, 2025
·
8 min read
Business
Interpace Biosciences Announces First Quarter 2024 Financial and Business Results
Interpace Biosciences, Inc. announced financial results for the first quarter ended March 31, 2024 and provided a business and financial update.
May 9, 2024
·
9 min read
Business
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results
Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the fourth quarter and full year ending December 31, 2023.
March 7, 2024
·
12 min read
Press Releases
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology
Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for Enhanced Diagnostic Capabilities
January 15, 2026
·
4 min read
1 of 11,090
Next
